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Background: Aortoenteric fistulas (AEFs) are a rare but often fatal cause of gastrointestinal bleeding. Operative repair of
AEF has been historically associated with extremely high morbidity and mortality. We reviewed our experience of open
surgical and endovascular treatment of AEF to compare outcomes over a contemporaneous time period.
Methods: Over a 9-year period between January 1997 and January 2006, 16 patients (11 men and 5 women) were
diagnosed with and treated for AEFs. Seven patients underwent open surgical repair, and nine, with anatomically suitable
lesions, underwent endovascular repair. The outcome after treatment of these patients was investigated for survival,
perioperative complications, length of hospital stay, and long-term disposition.
Results: Three primary and 13 secondary AEFs were treated. The mean time from the initial aortic operation until AEF
diagnosis was 5.9 years (range, 0.7-12.2 years) for patients with secondary AEFs. The overall 30-day mortality rate was
18.8%. One intraoperative death and one in-hospital death secondary to multisystem organ failure occurred in patients
undergoing open repair. One in-hospital death related to persistent sepsis occurred in the endovascular group. The overall
perioperative complication rate was 50.0%. Complications in the open group included sepsis, renal failure, bowel
obstruction, and pancreatitis. Complications in the endovascular group were related to persistent sepsis. The mean
in-hospital length of stay was significantly longer for patients undergoing open repair compared with endovascular repair
(44.0 vs 19.4 days; P  .04). Four (80%) of five patients who were discharged from the hospital in the open group were
placed in skilled nursing facilities, and seven (87.5%) of eight patients discharged in the endovascular group returned
home. The median overall survival after hospital discharge was 23.1 months. There were no late aneurysm-related deaths
or late deaths related to septic complications.
Conclusions: Patients with AEFs have limited overall survival. Endovascular therapy offers an alternative to open surgical
repair, seems to be associated with decreased perioperative morbidity and mortality and a shorter in-hospital stay, and
allows for acceptable survival given the presence of coexisting medical comorbidities. Furthermore, endovascular repair
provides a therapeutic option to control bleeding and allow for continued intervention in a stabilized setting. (J Vasc
Surg 2006;44:250-7.)Aortoenteric fistula (AEF) is one of the most challeng-
ing diagnostic and therapeutic entities in vascular surgery.
Primary AEFs have a reported incidence of 0.04% to
0.07%,1,2 whereas the development of secondary AEFs
complicates 0.36% to 1.6% of all aortic operations.3-6 Al-
though the overall incidence of AEF seems to be decreasing
and the diagnostic delays are shorter than they were histor-
ically,7 morbidity and mortality after repairs remain high.
Furthermore, the recently observed entity of AEF develop-
ment after endovascular aortic repair has emerged as an
additional causative factor.8-12
Traditional treatment of AEF has consisted of graft
excision and extra-anatomic bypass. Alternatives to this
have included in situ graft replacement and simple graft
excision alone. Since its inception, endovascular repair has
offered a less invasive alternative for the management of
aortic disease, including limited reports for the treatment of
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250AEF. We reviewed our experience with AEF over a 9-year
period, since the initiation of endovascular aortic repair at
our institution, and compared outcomes of patients treated
with open and endovascular repair.
PATIENTS AND METHODS
Demographics. Over a 9-year period between January
1997 and January 2006, 16 patients underwent repair of
AEFs at our institution, including 11 patients with second-
ary infrarenal AEFs. Of these 16 patients, 9 underwent
endovascular repair, and 7 underwent open repair. These
patients were identified through a search of a prospective
endovascular database and a review of medical records
based on diagnoses and procedures related to AEF. From
this search, no patient was identified who had been diag-
nosed with an AEF and did not undergo any therapy.
Medical records of all patients were investigated for patient
demographics and comorbidities, details of previous aortic
operations, clinical presentations of AEFs, methods of di-
agnosis, operative details, perioperative complications,
lengths of hospital stay, and long-term dispositions. Differ-
ences in patient demographics and outcomes between
those who were treated with open repair and those treated
with endovascular repair were analyzed by either Fisher
exact test or t-test analyses.
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tions of aortic fistulas in the open group included the esoph-
agus (n 1), stomach (n 1), and duodenum (n 5), and
in the endovascular group they were located in the esoph-
agus (n  2), duodenum (n  5), jejunum (n  1), and
sigmoid colon (n 1). For AEFs of all locations, the mean
age of patients undergoing endovascular repair was signif-
icantly older than the mean age of patients undergoing
open repair (78.6 years [range, 65-91 years] vs 66.3 years
[range, 54-80 years]; P .03). For patients with secondary
infrarenal AEFs, those undergoing endovascular repair
were older than those undergoing open repair, although
this difference did not reach statistical significance (78.8 vs
68.1 years; P.13). Overall, the entire endovascular group
had a mean of 3.7 comorbidities per patient, whereas the
entire open group had a mean of 3.1 comorbidities per
patient. Patients with secondary infrarenal AEFs were sim-
ilar in terms of comorbidities, with 3.7 per patient in the
endovascular group and 3.8 per patient in the open group
(Table I).
For the eight patients in the endovascular group with
secondary AEFs, all underwent their initial aortic operation
for aneurysmal disease (Table II). Four of these eight
patients underwent emergent aneurysm repairs for rupture.
Of the five patients in the open group with secondary AEFs,
four patients underwent their initial aortic operation for
aneurysmal disease, and one patient underwent aortic sur-
gery for occlusive disease. The patient who underwent his
initial operation for occlusive disease, an end-to-end aorto-
bifemoral bypass, required a revision secondary to limb
thrombosis of his graft. One patient developed a secondary
AEF after endovascular aortic repair with a device that has
transrenal bare stents but lacks hooks or any other sharp
fixation component. The mean interval from the time of
initial aortic surgery until the time of presentation of AEF
Table I. Patient demographics and preoperative
laboratory values
Variable
Open
(n  7)
Endovascular
(n  9)
Total
(n  16)
Mean age (y) 66.3 78.6 73.2
Male/female 5/2 6/3 11/5
Comorbidities
CAD 3 (42.9) 8 (88.9) 11 (68.8)
COPD 2 (28.6) 6 (66.7) 8 (50.0)
CVA 2 (28.6) 3 (37.5) 5 (31.3)
Hypercholesterolemia 5 (71.4) 5 (55.6) 10 (62.5)
HTN 5 (71.4) 7 (77.8) 12 (75.0)
DM 2 (28.6) 1 (12.5) 3 (18.8)
Malignancy 3 (42.9) 3 (37.5) 6 (37.5)
Preoperative laboratory
values
Mean WBC (103/L) 12.6 11.6 12.1
Mean hematocrit 31.0% 29.3% 30.1%
CAD, Coronary artery disease; COPD, chronic obstructive pulmonary dis-
ease; CVA, cerebrovascular accident; HTN, hypertension; DM, diabetes
mellitus; WBC, white blood cell count.for the entire cohort was 5.9 years (range, 0.7-12.2 years).In patients undergoing open repair, the mean interval was
3.2 years (range, 0.7-8.7 years), and in patients undergoing
endovascular repair, the mean interval was 7.4 years (range,
2.6-12.2 years).
Both patients in the open group with primary AEFs had
a history of esophageal carcinoma. One patient was treated
with preoperative chemoradiation before undergoing an
esophagogastrectomy 2 months before his presentation.
The second patient was also treated with chemoradiation
but was deemed to have unresectable disease and under-
went insertion of an esophageal stent 2 months before his
presentation. The patient in the endovascular group with a
primary fistula did not have any known gastrointestinal
disease but did have a large (8-cm) abdominal aortic aneu-
rysm.
Fourteen (87.5%) of the 16 patients presented with
overt gastrointestinal bleeding in the form of either he-
matemesis or melena. Four of these patients, including two
in the endovascular and two in the open group, presented
with massive gastrointestinal bleeding and associated he-
modynamic instability. Two patients presented with ab-
dominal pain and had evidence of gastrointestinal bleeding
on fecal occult blood testing and laboratory studies. Twelve
of the 16 patients initially presented to outside institutions
and were treated for a mean of 3.1 days (range, 1-13 days)
before admission at our institution. Two of these patients
had multiple hospital visits over the preceding months for
gastrointestinal bleeding. No patient died while awaiting
transfer or during the transfer process itself.
All patients in the endovascular group underwent
esophagogastroduodenoscopy (EGD) and computed to-
mography (CT) scanning before repair. Additionally, two
patients in this group had angiograms performed. In the
open group, all patients underwent EGD, and five patients
had CT scans before repair. Similarly, two patients in this
group had angiograms performed, and a single patient under-
went a radionuclide white blood cell scan. In both groups,
angiogramswere performed to determine the source of bleed-
ing in cases that were unclear and not specifically to clarify
anatomy for operative planning. Overall, EGD findings
consistent with AEF, including active bleeding, ulceration,
fistula tract, or visible graft, were seen in 10 (62.5%) of 16
patients. Three patients had a visible graft, and the remain-
ing seven had one or more of the aforementioned findings
at an anatomic location that was consistent with the diag-
nosis of AEF. For select patients, including those with
esophageal cancer and primary AEFs, EGD findings were
indicative of AEF, but the diagnosis was not confirmed
until the time of operation. Of the 14 patients who had CT
scanning, 12 (85.7%) had abnormalities indicative of AEF,
including loss of the fat plane between the intestine and the
aorta, air or fluid around the aorta, or direct communica-
tion between the intestinal lumen and the aorta (Fig 1). Of
the four patients who underwent angiography, none had
active bleeding to provide definitive evidence of AEF. Two
patients underwent operation as a result of continued gas-
trointestinal bleeding with the presumed diagnosis of AEF
despite inconclusive CT and endoscopic findings.
oraco
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tients were started on broad-spectrum intravenous antibi-
otics before surgery once the diagnosis of AEF was made.
All patients who underwent endovascular repair were
determined to be at high risk for open repair and had
lesions that were anatomically suitable on the basis of
preoperative CT angiography, including the presence of an
adequate proximal neck and access vessels that were of
appropriate size and limited tortuosity to allow for passage
of endovascular devices.
The devices that were used for endovascular repair in-
cluded custom-made Parodi (Johnson and Johnson, Som-
merville, NJ)/Palmaz (Impra, C. R. Bard, Murray Hill, NJ)
aortouni-iliac devices in three patients, Talent (Medtronic,
Minneapolis, Minn) tube grafts in two patients, a Talent
bifurcated graft in one patient, the bifurcated Gore Excluder
(W. L. Gore, Flagstaff, Ariz) in two patients, and the Gore
TAG thoracic device in one patient. The endovascular proce-
dures were all performed in the operating room with patients
prepared and draped in preparation for possible conversion to
open repair. Anesthesia for these nine cases included general
endotracheal anesthesia for four patients, epidural anesthesia
for three patients, and local anesthesia with lidocaine in two
patients. Stent-graft placement of infrarenal aortic devices was
performed via bilateral femoral artery cutdowns under C-arm
fluoroscopic guidance. Placement of thoracic aortic devices
was performed via unilateral femoral artery cutdown and
percutaneous access of the contralateral femoral artery. Pa-
tients who were clinically well without evidence of ongoing
blood loss and without evidence of sepsis were started on oral
feedingonpostoperative day 1. Select patientswith decreasing
hematocrits underwent postoperative endoscopic evaluation
Table II. Characteristics of aortoenteric fistulas
Patient no. Location Type Previous aortic surge
Open group
1 Aortoesophageal 1° None
2 Aortogastric 1° None
3 Aortoduodenal 2° Endovascular AAA rep
4 Aortoduodenal 2° Open AAA repair
5 Aortoduodenal 2° Aortobifemoral bypass
6 Aortoduodenal 2° Open AAA repair
7 Aortoduodenal 2° Open AAA repair
Endovascular group
1 Aortoesophageal 2° Open TAA repair
2 Aortoesophageal 2° Open ThAA repair
3 Aortoduodenal 2° Open AAA repair
4 Aortoduodenal 1° None
5 Aortoduodenal 2° Open AAA repair
6 Aortoduodenal 2° Open AAA repair (rupt
7 Aortoduodenal 2° Open AAA repair (rupt
8 Aortojejunal 2° Open AAA repair (rupt
9 Aortosigmoid 2° Open AAA repair (rupt
AAA,Abdominal aortic aneurysm;TAA, thoracic aortic aneurysm;ThAA, thto confirm cessation of AEF bleeding. All patients were placedon lifelong suppressive oral antibiotics after their endovascular
repairs; these were organism specific in the setting of positive
perioperative cultures. Follow-up CT scans were obtained at
1, 6, and 12 months and annually thereafter, in accordance
with our protocol for patients who undergo endovascular
repair of aneurysmal disease (Fig 2).
Of the seven patients who underwent open repair, four
underwent axillary-bifemoral bypass before graft excision
and fistula repair. Three of these were performed immedi-
ately before repair, and one was staged 3 days before
definitive repair. Additionally, one patient underwent
axillary-bifemoral bypass after graft excision and fistula
repair. The patient with the aortogastric fistula underwent
primary aortic repair without extra-anatomic bypass, and
the patient with the aortoesophageal fistula underwent
attempted primary aortic repair as well. Of the five patients
who underwent open repair of secondary AEFs, two required
suprarenal clamping to obtain aortic control, whereas three
required supraceliac clamping. Retrospectively, the two pa-
tients who required suprarenal clamping may have had anat-
omy that was suitable for endovascular treatment, but these
patients were deemed fit for open repair and were deter-
mined to have less than ideal anatomy for endovascular
repair on the basis of their preoperative imaging. Open
repair included wide drainage and, when possible, place-
ment of omentum in the aortic graft bed. Intestinal repair
consisted of debridement and primary closure for four
patients, resection with anastomosis for one patient, and
resection with diversion for one patient.
RESULTS
Perioperative adverse events. The overall 30-day mor-
Interval from previous
aortic surgery (y) Positive perioperative blood culture
N/A None
N/A Staphylococcus aureus
0.7 Staphylococcus aureus, Enterobacter
cloacae
2.8 Staphylococcus hominis
8.7 Enterobacter cloacae, Enterobacter
faecium
3.0 Enterobacter cloacae
2.9 Streptococcus milleri
5.2 Klebsiella pneumoniae
6.9 Aspergillus fumigatus
12.2 None
N/A None
6.1 Streptococcus salivarius, Pseudomonas
aeruginosa
2.6 None
12.1 None
5.0 None
9.0 Enterobacter cloacae
abdominal aortic aneurysm; 1°, primary; 2°, secondary; N/A, not applicable.ry
air
ure)
ure)
ure)
ure)tality rate was 18.8% (3/16), including 2 deaths in the open
t the
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one intraoperative death in the open group from cardiopul-
monary arrest due to uncontrolled hemorrhage and one
death 14 days after surgery from persistent sepsis. The
Fig 1. A, Endoscopic image demonstrating an aorto
hematemesis and had undergone open thoracic aortic an
scan of the same patient demonstrating fluid collection
object in the esophageal lumen is a metallic clip placed adeath in the endovascular group was due to fungal sepsisafter repair of an aortoesophageal fistula. The 30-day mor-
tality rate for patients with secondary infrarenal AEF was
9.1% (1/11), which occurred, as above, as a result of
persistent sepsis in a patient with an aortoduodenal fistula
hageal fistula tract in a patient who presented with
m repair 5 years previously. B, Computed tomographic
d the aorta and contrast extravasation. The radiodense
time of endoscopy.esop
eurys
arounwho presented with massive gastrointestinal bleeding ne-
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bifemoral bypass.
Overall, perioperative complications occurred in 8
(50%) of 16 patients (Table III). In the open group,
these consisted of acute renal failure necessitating hemo-
dialysis, bowel obstruction necessitating exploratory lap-
arotomy and lysis of adhesions, mediastinal abscess ne-
cessitating multiple operative drainages, multisystem
organ failure, and pancreatitis. Complications in the
endovascular group were related to persistent sepsis in
three patients, and this led to multisystem organ failure
Fig 2. A, Computed tomographic scan performed o
changes around the aorta and contrast within the intestin
after successful endovascular repair.in one patient. Perioperative complications occurred in 6(54.5%) of 11 patients undergoing repair of a secondary
infrarenal AEFs, including 4 (80.0%) of 5 in the open
group and 2 (33.3%) of 6 in the endovascular group. The
first complication in the endovascular group occurred in
a patient with an aortosigmoid fistula who developed a
retroperitoneal abscess necessitating drainage and a di-
verting ileostomy on postoperative day 2. He subse-
quently underwent a Hartmann procedure on postoper-
ative day 8. A second patient with a large perigraft
collection from an aortoduodenal fistula underwent per-
cutaneous CT-guided drainage for persistent sepsis after
ith intravenous contrast demonstrating inflammatory
en.B,Computed tomographic angiography 12 monthsnly w
al lumstent-graft placement.
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overall length of stay for patients who were successfully
discharged from the hospital was 28.8 days. The mean
length of stay was significantly longer in the open group
compared with the endovascular group (44.0 vs 19.4 days;
P  .04). For patients undergoing repair of a secondary
infrarenal AEF, there was a trend toward a longer mean
length of stay in the open group compared with the endo-
vascular group (35.5 vs 23.0 days; P .32). Overall, in the
open group, four of five discharged patients were placed in
skilled nursing facilities. In the endovascular group, seven
of eight discharged patients returned home, although two
required temporary visiting nurse services. After repair of
secondary infrarenal AEFs, three of four patients in the
open group were placed in skilled nursing facilities, whereas
all six discharged patients in the endovascular group re-
turned home.
Late complications and mortality. There were two
late infectious-related complications in the endovascular
group, both after repair of secondary infrarenal AEFs. One
patient was hospitalized twice, 2 and 6 months after his
repair, for bacteremic episodes, which were both treated
with intravenous antibiotics. CT scans were obtained at
each hospitalization and failed to demonstrate any intra-
abdominal fluid collections. A second patient developed a
pseudoaneurysm at the distal anastomosis of a prosthetic
femoral artery interposition graft that had been placed at
the time of stent-graft deployment because of arterial dam-
age. This was successfully managed with graft excision and
replacement with an autologous vein graft 14 months after
her AEF repair. There were no late amputations, embolic
events, or graft thromboses in either group.
The median overall survival after hospital discharge was
23.1 months (range, 1-49 months). Median survival in the
Table III. Perioperative complications and disposition
Patient no. Perioperative complications Length of sta
Open group
1 Intraoperative death 1
2 Mediastinal abscess 78
3 Bowel obstruction 50
4 Acute renal failure 45
5 Pancreatitis 28
6 Multisystem organ failure 14
7 None 19
Endovascular group
1 None 10
2 Multisystem organ failure 17
3 None 13
4 None 7
5 Persistent sepsis 32
6 None 2
7 None 32
8 None 5
9 Persistent sepsis 54
*N/A, not applicableopen group was 38.0 months, compared with 12.3 monthsin the endovascular group (P  .10). Of patients under
going repair of a secondary infrarenal AEF, the median
overall survival in the open group was 36.5 months, com-
pared with 12.3 months in the endovascular group (P 
.23). Overall, there were four late deaths in the entire open
group: three from unknown causes and one from lung
cancer. There were six late deaths in the entire endovascular
group: three from myocardial infarctions, one from a pul-
monary embolism, one from a cerebrovascular accident,
and one from metastatic breast cancer.
DISCUSSION
Although AEFs are relatively rare, they continue to be a
morbid and often mortal complication of aortic aneurysms.
The exact pathogenesis of the development of AEF has not
been fully elucidated, but both mechanical erosion and
infection are thought to play a role.3,5,13,14 Furthermore,
recently there have been multiple reports of AEFs develop-
ing after endovascular aortic repair, despite the theoretical
lack of extraluminal disruption.8-12 Regardless of etiology,
the traditionalmanagement goals ofAEFhavebeen to control
hemorrhage, to control infection, and to maintain adequate
distal perfusion: these have been achieved through graft ex-
cision and extra-anatomic bypass. In recent years, endovas-
cular repair has emerged as another therapeutic option,
particularly for the rapid control of bleeding from AEF.
Despite technological advances, the cornerstone of di-
agnosing AEF continues to be clinical suspicion. Initial
bleeding is usually minor and is often self-limited, and this
may lead to a delay in definitive diagnosis. Additionally, the
time from the “herald bleed” to massive rebleeding may be
hours to months. This delay was seen in our series, in which
12 of 16 patients initially presented to outside institutions
and were hospitalized for a mean of 3.1 days before trans-
Disposition Survival after discharge (mo)
In-hospital death N/A*
Extended care facility Alive at 33
Extended care facility 47
Extended care facility 26
Home 49
In-hospital death N/A
Extended care facility 1
Extended care facility Alive at 1
In-hospital death N/A
Home with visiting
nurse services
Alive at 18
Home 27
Home 10
Home 5
Home 40
Home 3
Home with visiting
nurse services
15y (d)fer. Furthermore, bleeding may result from direct commu-
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lumen or from graft erosion into the intestinal wall leading
to hemorrhage from the intestinal wall edges. For the latter
scenario, endovascular repair is less likely to be effective in
controlling blood loss than open repair.
CT scanning has been advocated as the preferred initial
diagnostic test for patients with AEF, with a reported
sensitivity of up to 93%.15,16 In our series, there was an
85.7% sensitivity (12 of 14 patients who underwent CT
scanning) in detecting AEF. EGD has less sensitivity than
CT scanning, with reported findings in 25% to 80%,1,3,5,7
similar to the sensitivity of 62.5% in our patients. EGD
should be performed by an experienced endoscopist and
may require a pediatric colonoscope to appropriately eval-
uate the entire duodenum. Additionally, colonoscopy may
be useful in patients who present with gastrointestinal
bleeding, previous aortic repair, and a negative EGD, given
the possibility of aortocolonic fistulization, as in one patient
in our series. Angiography should be reserved for patients
in whom the diagnosis of AEF is unclear to help determine
a source of bleeding.
For stable patients with minimal comorbidities and
significant life expectancies, surgical management of AEF
via staged extra-anatomic bypass followed by graft excision
is optimal because it provides definitive management, limits
lower extremity ischemia, and allows for patient recovery
between operations. This has been shown to be relatively
safe, but it is still associated with a significant mortality of
up to 27%.5,17 Simultaneous repair of extra-anatomic by-
pass followed immediately by graft excision is an acceptable
alternative that has also been shown to be feasible, with
acceptable morbidity and mortality.3,15 Additional surgical
options include graft excision alone, graft excision with
in situ replacement, and primary repair, all of which should
be reserved for select patients.18 Management of the intes-
tinal portion of fistulas has been demonstrated to have
acceptable outcomes with simple bowel repair, although
resection may be necessary for certain patients.19
Patients with AEFs who present with shock, require
preoperative transfusions, and need suprarenal aortic con-
trol during repair have a higher associated early mortality.15
Furthermore, patients with AEFs often have multiple co-
morbidities and limited life expectancies that may place
them at high risk for open repair. Endovascular aortic repair
offers patients in these populations a less invasive alternative
to seal the fistula and control bleeding.20-24 However,
unlike open repair with graft excision, the likely-infected
graft and/or aorta remains in situ, and this places the newly
implanted stent graft at risk for infection. A variety of
adjunctive therapies have been used to both rapidly control
hemorrhage and decrease the risk of persistent infection,
including fibrin sealant instillation into a fistula tract25 and
the injection of n-butyl 2-cyanoacrylate into a fistula
tract,26 both followed by stent-graft placement. Although
these techniques may help, endovascular repair is limited
because it does not include intestinal repair. On the basis of
our experience, select patients may heal their AEFs after
endovascular repair coupled with antibiotic therapy, partic-ularly those with secondary infrarenal AEFs who present
without evidence of sepsis. However, for patients with
AEFs involving the esophagus or the colon who undergo
endovascular repair, additional procedures should be in-
cluded in most cases to decrease the risk of persistent sepsis.
This may include open intestinal repair or simple diversion
alone. For patients who present with overt sepsis and have
prohibitive comorbidities to immediate open repair, endo-
vascular repair, when coupled with percutaneous or even
open drainage, may serve as a palliative measure. Addition-
ally, for patients who may be medically optimized, endo-
vascular repair may serve as a bridging therapy to open
repair, particular if patients have ongoing sepsis or other
infectious complications. In our series, two patients had
persistent infectious complications after endovascular re-
pair. The first patient, who had an aortosigmoid fistula,
underwent two gastrointestinal procedures and was dis-
charged home. He was later offered and refused any addi-
tional interventions and died 18 months after repair from a
cerebrovascular accident. The second patient, who had an
aortoduodenal fistula, was 88 years old and had unrecon-
structable coronary artery disease, chronic obstructive pul-
monary disease, and renal insufficiency; was thought not to
be a candidate for conversion; and died 11 months after
repair from a myocardial infarction.
In our series, the overall endovascular group, as well as
those who underwent endovascular repair of secondary
infrarenal AEFs, had a lower incidence of perioperative
complications and a shorter length of hospital stay com-
pared with those who underwent open repair. Further-
more, nearly all of the endovascular patients could be
discharged home, whereas most patients who underwent
open repair required placement in skilled nursing facilities.
It is interesting to note that the median overall survival after
discharge was longer in the open group, but this is most
likely related to the number and severity of the comorbidi-
ties in the endovascular group, in addition to their signifi-
cantly older age. Given these data, endovascular repair as a
palliative procedure for select patients is valuable by allow-
ing for relatively short hospital stays and discharge to home.
This study is limited by its retrospective nature and
relatively small number of patients. Furthermore, patients
who develop AEFs and undergo repair represent a diverse
spectrum of general medical conditions. Although compar-
isons between the two groups have been made, the modal-
ity for treatment for each patient was individualized on the
basis of anatomy, underlying medical comorbidities, and,
to some extent, expected long-term survival. Overall, pa-
tients undergoing endovascular repair in this series tended
to represent a more morbid cohort with a shorter life
expectancy, and this must be considered when the data are
interpreted.
CONCLUSION
AEFs remain an often fatal complication of aortic re-
pair. Despite advances in imaging and endoscopic technol-
ogy, diagnostic dilemmas have continued.Conventional open
repair continues to be associated with significant perioperative
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Endovascular repair, which seems to be associated with de-
creased perioperative morbidity and mortality and a shorter
in-hospital stay, provides an alternative therapeutic option
to control bleeding and allow for continued intervention in
a stabilized setting. Patients with overt sepsis or AEFs
involving the esophagus or colon and prohibitive comor-
bidities to open repair may be candidates for endovascular
repair but should also undergo drainage, intestinal repair, or
diversion to minimize the risk of ongoing infectious compli-
cations. Furthermore, for patients with multiple comorbidi-
ties and limited life expectancies, endovascular repair cou-
pled with lifelong suppressive antibiotic therapy may allow
for freedom from further complications related to the AEF.
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